Table 2 Antimicrobial resistance among animal, human and miscellaneous sources of S. Senftenberg
Antimicrobial | Breakpoint | Animal (n = 71) | Human (n = 22) | Other (n = 5) |
|---|---|---|---|---|
Amikacin (AMI) | ≥64 | 0 | 0 | 0 |
Amoxicillin/Clavulanic Acid (AUG) | ≥32/16 | 7 (9.8%) | 0 | 0 |
Ampicillin (AMP) | ≥32 | 14 (19.7%) | 0 | 0 |
Cefoxitin (FOX) | ≥32 | 8 (11.2%) | 0 | 0 |
Ceftiofur (TIO) | ≥8 | 8 (11.2%) | 0 | 0 |
Ceftriaxone (AXO) | ≥4 | 8 (11.2%) | 0 | 0 |
Chloramphenicol (CHL) | ≥32 | 11 (15.4%) | 0 | 0 |
Ciprofloxacin (CIP) | ≥4 | 0 | 0 | 0 |
Gentamicin (GEN) | ≥16 | 13 (18.3%) | 0 | 1 (20%) |
Kanamycin (KAN) | ≥64 | 26 (36.6%) | 0 | 1 (20%) |
Nalidixic Acid (NAL) | ≥32 | 0 | 0 | 0 |
Streptomycin (STR) | ≥64 | 21 (29.5%) | 0 | 1 (20%) |
Sulfisoxazole (FIS) | ≥256 | 37 (52.1%) | 0 | 1 (20%) |
Tetracycline (TET) | ≥16 | 34 (47.8%) | 0 | 1 (20%) |
Trimethroprim/Sulfamethoxazole (SXT) | ≥4/76 | 11 (15.4%) | 0 | 0 |